RS:NYSEReliance, Inc. Analysis
Data as of 2026-04-29 - not real-time
$362.42
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Reliance, Inc. (RS) is trading at $362.42, comfortably above its 20‑day ($327.41), 50‑day ($316.00) and 200‑day ($300.96) moving averages, indicating a strong bullish trend. Technical momentum is reinforced by a bullish MACD (12.51 vs signal 8.16) and an increasing volume pattern, though the RSI of 78.7 suggests the stock is overbought and vulnerable to a short‑term pullback near the $365 resistance. Recent Q1 2026 results beat expectations, with earnings of $5.10 per share up from $3.74 YoY and revenue up 15.5%, driven by higher selling prices and new government contracts. Fundamentally, the company shows solid growth: forward EPS of $20.57 implies a forward P/E of 17.6, while the current P/E of 23.6 and price‑to‑book of 2.6 are modest for the steel sector. However, the DCF fair value of $176 indicates the market is pricing in a significant premium, reflected in the -3.7% downside metric and analyst targets (~$347) below the current price. The dividend yield of 1.38% with a 31.6% payout ratio appears sustainable given stable cash flow, but net debt of $2.03 B versus $0.25 B cash raises balance‑sheet caution. Overall, the stock benefits from an “Extreme Greed” sentiment (fear‑greed index 89.6) and low beta (0.75), yet its valuation and sector cyclicality warrant careful positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI overbought at 78.7 indicating near‑term pullback risk
- Price approaching $365 resistance level
- Strong technical momentum but limited upside in the next weeks
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 15% YoY revenue growth and earnings beat in Q1 2026
- Forward P/E of 17.6 suggests attractive valuation relative to growth
- Sustainable dividend and improving operating cash flow
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Cyclical nature of the steel industry and exposure to commodity pricing
- Balance‑sheet leverage (debt‑to‑equity 28.4%) requiring monitoring
- Long‑term growth prospects from diversified metal solutions and government contracts
Key Metrics & Analysis
Financial Health
Revenue Growth15.50%
Profit Margin5.42%
P/E Ratio23.6
ROE11.33%
ROA6.73%
Debt/Equity28.45
P/B Ratio2.6
Op. Cash Flow$918.3M
Free Cash Flow$420.8M
Technical Analysis
TrendBullish
RSI78.7
Support$298.28
Resistance$365.00
MA 20$327.41
MA 50$316.00
MA 200$300.96
MACDBullish
VolumeIncreasing
Fear & Greed Index89.59
Valuation
Fair Value$176.02
Target Price$349.00
Upside/Downside-3.70%
GradeOvervalued
TypeGrowth
Dividend Yield1.38%
Risk Assessment
Beta0.75
Volatility24.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.